newsfilter
← Latest News
Business Wire·

Cortexyme Announces Change in Executive Leadership Team

Christopher Lowe appointed interim chief executive officer David Lamond named chairman of the board Cortexyme, Inc. (NASDAQ:CRTX), a clinical-stage biopharmaceutical company focused on Alzheimer's and other degenerative diseases, today announced t